These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25920015)

  • 1. Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume analysis.
    Mazzola R; Ricchetti F; Fersino S; Fiorentino A; Giaj Levra N; Di Paola G; Ruggieri R; Alongi F
    Head Neck; 2016 Apr; 38 Suppl 1():E815-9. PubMed ID: 25920015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of oral mucosa dose and volume parameters with Grade 3 mucositis, in patients treated with volumetric modulated arc radiotherapy for oropharyngeal cancer?
    Bansal A; Bedi N; Kaur R; Singh G; Benipal RPS; Dangwal V
    Jpn J Clin Oncol; 2023 Mar; 53(4):313-320. PubMed ID: 36546704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer.
    Sanguineti G; Sormani MP; Marur S; Gunn GB; Rao N; Cianchetti M; Ricchetti F; McNutt T; Wu B; Forastiere A
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):235-42. PubMed ID: 22104358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Dose to an Oral Mucosa Organ at Risk Predict the Duration of Grade 3 Mucositis after Intensity-modulated Radiotherapy for Oropharyngeal Cancer?
    Yahya S; Benghiat H; Nightingale P; Tiffany M; Sanghera P; Hartley A
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):e216-e219. PubMed ID: 27593973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional recurrences after post-operative volumetric modulated arc radiotherapy (VMAT) in oral cavity cancers in a resource constrained setting: experience and lessons learned.
    Chakraborty S; Patil VM; Babu S; Muttath G; Thiagarajan SK
    Br J Radiol; 2015 Apr; 88(1048):20140795. PubMed ID: 25645107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer.
    Sanguineti G; Gunn GB; Parker BC; Endres EJ; Zeng J; Fiorino C
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):52-9. PubMed ID: 20418027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for Reducing Normal Tissue Complication Probabilities in Oropharyngeal Cancer: Dose Reduction or Planning Target Volume Elimination.
    Samuels SE; Eisbruch A; Vineberg K; Lee J; Lee C; Matuszak MM; Ten Haken RK; Brock KK
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):645-52. PubMed ID: 27681761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delineation for oral cavity and oropharyngeal cancers].
    Lapeyre M; Loos G; Biau J
    Cancer Radiother; 2013 Oct; 17(5-6):493-7. PubMed ID: 23973455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclined head position improves dose distribution during hippocampal-sparing whole brain radiotherapy using VMAT.
    Kim KS; Seo SJ; Lee J; Seok JY; Hong JW; Chung JB; Kim E; Choi N; Eom KY; Kim JS; Kim IA
    Strahlenther Onkol; 2016 Jul; 192(7):473-80. PubMed ID: 27221313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-isocentric 4π volumetric-modulated arc therapy approach for head and neck cancer.
    Subramanian VS; Subramani V; Chilukuri S; Kathirvel M; Arun G; Swamy ST; Subramanian K; Fogliata A; Cozzi L
    J Appl Clin Med Phys; 2017 Sep; 18(5):293-300. PubMed ID: 28834021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study for reducing lung dose of upper thoracic esophageal cancer radiotherapy by auto-planning: volumetric-modulated arc therapy vs intensity-modulated radiation therapy.
    Chen H; Wang H; Gu H; Shao Y; Cai X; Fu X; Xu Z
    Med Dosim; 2018 Autumn; 43(3):243-250. PubMed ID: 29110926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.
    Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F
    J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous integrated vs. sequential boost in VMAT radiotherapy of high-grade gliomas.
    Farzin M; Molls M; Astner S; Rondak IC; Oechsner M
    Strahlenther Onkol; 2015 Dec; 191(12):945-52. PubMed ID: 26340939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SmartArc-based volumetric modulated arc therapy for oropharyngeal cancer: a dosimetric comparison with both intensity-modulated radiation therapy and helical tomotherapy.
    Clemente S; Wu B; Sanguineti G; Fusco V; Ricchetti F; Wong J; McNutt T
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1248-55. PubMed ID: 20947268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.
    Vanetti E; Clivio A; Nicolini G; Fogliata A; Ghosh-Laskar S; Agarwal JP; Upreti RR; Budrukkar A; Murthy V; Deshpande DD; Shrivastava SK; Dinshaw KA; Cozzi L
    Radiother Oncol; 2009 Jul; 92(1):111-7. PubMed ID: 19157609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obtaining normal tissue constraints using intensity modulated radiotherapy (IMRT) in patients with oral cavity, oropharyngeal, and laryngeal carcinoma.
    Skinner WK; Muse ED; Yaparpalvi R; Guha C; Garg MK; Kalnicki S
    Med Dosim; 2009; 34(4):279-84. PubMed ID: 19854386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute mucosal radiation reactions in patients with head and neck cancer. Patterns of mucosal healing on the basis of daily examinations.
    Wygoda A; Składowski K; Rutkowski T; Hutnik M; Goleń M; Pilecki B; Przeorek W; Lukaszczyk-Wideł B
    Strahlenther Onkol; 2012 Aug; 188(8):686-91. PubMed ID: 22729281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
    Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
    Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of low-level laser therapy in the prevention and treatment of radiation-induced mucositis: a double-blind randomized study in head and neck cancer patients.
    Carvalho PA; Jaguar GC; Pellizzon AC; Prado JD; Lopes RN; Alves FA
    Oral Oncol; 2011 Dec; 47(12):1176-81. PubMed ID: 21911312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is IMAT the ultimate evolution of conformal radiotherapy? Dosimetric comparison of helical tomotherapy and volumetric modulated arc therapy for oropharyngeal cancer in a planning study.
    Servagi Vernat S; Ali D; Puyraveau M; Viard R; Lisbona A; Fenoglietto P; Bedos L; Makovicka L; Giraud P
    Phys Med; 2014 May; 30(3):280-5. PubMed ID: 23948367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.